SCHEMBL26323599

SCHEMBL26323599

CCc1cc(N(C)c2ccc3[nH]c(-c4ccc(Nc5cc(C)nc6ccc(N7CCOCC7)cc56)nc4)nc3c2)ccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.42
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SIRT2 Q8IXJ6 1/20 0.37
▸ SIRT1 Q96EB6 1/20 0.37
▸ SYK P43405 3/20 0.35
▸ SRPK1 Q96SB4 1/20 0.35
▸ TERT O14746 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ CBFB Q13951 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ DGAT1 O75907 1/20 0.33
▸ SOAT1 P35610 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26321416 0.93 MAPKAPK2 (0.40) SIRT2SIRT1SYKSRPK1TERT
SCHEMBL26323629 0.92 MAPT (0.42) MAPTPOLBTSHRMAPK1KMT2A
SCHEMBL26323497 0.91 MAPT (0.50) MAPTPOLBTSHRMAPK1KMT2A
SCHEMBL26323573 0.87 MAPT (0.47) MAPTPOLBTSHRMAPK1KMT2A
SCHEMBL26321428 0.85 MAPKAPK2 (0.40) SIRT2SIRT1SYKSRPK1TERT
SCHEMBL26323527 0.84 MAPT (0.49) MAPTPOLBTSHRMAPK1KMT2A
SCHEMBL23999434 0.82 MAPT (0.46) MAPTPOLBTSHRMAPK1KMT2A
SCHEMBL30180640 0.82 MAPT (0.46) MAPTPOLBTSHRMAPK1KMT2A
SCHEMBL26321396 0.79 SLC2A1 (0.42) MAPTSRPK1PARP1CBFBFLT3
SCHEMBL26323550 0.79 MAPT (0.47) MAPTPOLBTSHRMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MAPT 3962/4885POLB 2552/4885TSHR 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback